Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
CA 2340455 A1 · Owner: Madura, Rebecca Anne · Inventors: Madura, Rebecca Anne; King, Kendall Wayne; Rosey, Everett Lee
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to mhp3 nucleic acids and proteins encoded by the, foregoing. The present invention further relates to novel apoprotein antigens encoded by, mhp3 for use in vaccines to prevent and treat diseases caused by infection with Mycoplasma, hyopneumoniae. The invention further relates to methods for the recombinant production of, such antigens.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 28, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 28, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 28, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.